
Strykr Analysis
NeutralStrykr Pulse 58/100. The market is paralyzed, but optionality is cheap. Threat Level 3/5.
If you want to know how much conviction there is in the inflation trade right now, look at the Treasury Inflation-Protected Securities (TIPS) market. Or, more accurately, squint at the flatline. As of February 7, 2026, $TIP sits at $110.65, unchanged, as if daring traders to make the first move. The silence is deafening. This is the asset class that’s supposed to be the canary in the coal mine for inflation. Instead, it’s looking more like Schrödinger’s canary: neither alive nor dead, just waiting for the next macro observer to open the box.
The backdrop is anything but quiet. In the last 24 hours, the market’s narrative has been shredded by a barrage of headlines: tariffs are about to start biting in the January CPI, Fed officials are out on the circuit swearing allegiance to the 2% inflation target, and Wall Street is openly debating whether the AI spending boom is a growth engine or a ticking time bomb. Meanwhile, $TIP refuses to budge, as if the bond market has developed a Zen-like detachment from the chaos.
Let’s run through the tape. Seeking Alpha warns that the full effects of tariffs will hit the January CPI report, a potential landmine for anyone betting on a smooth disinflation glide path. Outgoing Atlanta Fed President Raphael Bostic is on Bloomberg, sounding hawkish about inflation risks and the need for vigilance. The AI narrative, once the market’s darling, is now being questioned as infrastructure costs explode and the old-economy rotation gathers steam. Even the S&P 500 Equal Weight Index just hit an all-time high, a sign that the mega-cap tech trade is no longer the only game in town.
Yet, $TIP is unmoved. No panic, no euphoria, just a market in suspended animation. This isn’t complacency, it’s paralysis. The TIPS market is caught between two competing forces: sticky inflation risk driven by tariffs and supply chain frictions, and the growing sense that the Fed will have to keep rates higher for longer to keep the genie in the bottle. The result is a standoff, with neither bulls nor bears willing to stick their necks out.
Historically, TIPS have been the go-to hedge for inflation spikes. In 2021, when CPI prints shocked to the upside, TIPS yields cratered and prices soared. But now, with the Fed’s credibility on the line and the market hyper-attuned to every data print, the playbook is less clear. The bond market is sniffing out something more nuanced: not a runaway inflation spiral, but a world where inflation is sticky enough to keep real yields elevated, but not high enough to trigger a full-blown panic.
The cross-asset signals are just as muddled. Equities are showing a growing divergence between AI darlings and old-economy stalwarts, while commodities are stuck in a holding pattern. The dollar is treading water, and volatility is subdued across the board. It’s as if the entire macro complex is on pause, waiting for the next shoe to drop.
The real story here is that the TIPS market is telling you to stay nimble. The inflation debate is far from settled, and the risks are asymmetric. If tariffs push CPI higher and the Fed blinks, TIPS could catch a bid in a hurry. But if growth rolls over or the Fed doubles down on hawkish rhetoric, real yields could spike and TIPS could get clubbed. Either way, the days of easy money in the inflation trade are over.
Strykr Watch
Technically, $TIP is glued to the $110.65 level, with support at $109.80 and resistance at $112.00. The 50-day moving average is flat, RSI is stuck near 48, and there’s no momentum to speak of. This is a market waiting for a catalyst. Watch for a break of $112.00 on a hot CPI print or a hawkish Fed pivot. Conversely, a drop below $109.80 would signal that the market is pricing in a growth scare or a deflationary shock.
Positioning is light, with open interest in TIPS futures near multi-year lows. The options market is pricing in just 0.7% implied volatility for the next month, the lowest since 2019. In other words, nobody is betting on fireworks, yet.
The risk is that everyone is on the same side of the boat. If inflation surprises to the upside, the scramble for protection could be violent. On the flip side, if growth data disappoints or the Fed signals a longer pause, TIPS could get hit as real yields surge.
The market is giving you a gift: cheap optionality. The move will be sharp when it comes, and the best trades will be the ones that get in before the crowd wakes up.
The bear case is simple: tariffs prove to be a paper tiger, CPI comes in soft, and the Fed stays on hold. In that world, real yields grind higher and TIPS underperform. The bull case is that inflation re-accelerates, the Fed is forced to react, and TIPS rip higher as the market scrambles for protection.
For traders, the opportunity is to play the range with tight stops, or to position for a breakout with optionality. Long TIPS calls or call spreads offer cheap convexity if inflation surprises. Shorting TIPS on a break below $109.80 is the play if you think the growth scare is real.
Strykr Take
The TIPS market is the eye of the storm right now. The next move will be violent, not gradual. Don’t get lulled by the flatline. This is the time to load up on optionality and get paid for being early. When the CPI hits and the Fed blinks, you’ll want to be on the right side of the trade. Strykr Pulse 58/100. Threat Level 3/5.
Sources (5)
NYSE's Reinking Weighs in on AI Trade Concerns
It's interesting that the S&P 500 Equal Weight (SPXEW) hit a new all-time high yesterday, posits Michael Reinking. He adds that concerns around AI spe
The Full Effects Of Tariffs To Start Showing Up In January CPI Report
The Full Effects Of Tariffs To Start Showing Up In January CPI Report
Wall Street's wild week rattles investors' confidence while highlighting a growing divide within markets
“It seems like there are two different markets right now,” one strategist says.
From AI Darlings To Dow Dinosaurs: Investors Flee Software For Old-Economy Stocks
Software and other AI-exposed stocks have stumbled out of the gate this year, with the sell-off picking up pace in February as fresh fears emerged tha
Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli
